‌

‌

‌
‌
‌‌

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Preferences in Cyclin-Dependent Kinase 4/6 Inhibitors for Advanced Breast Cancer Among Medical Oncologists in Latin America.

Preferences in Cyclin-Dependent Kinase 4/6 Inhibitors for Advanced Breast Cancer Among Medical Oncologists in Latin America.

Journal: JCO global oncology
Published: March 19, 2026

Breast Metastasis From Cutaneous Melanoma: Beyond the Infiltrating Ductal Carcinoma.

Breast Metastasis From Cutaneous Melanoma: Beyond the Infiltrating Ductal Carcinoma.

Journal: Cureus
Published: May 23, 2024

Acute Glomerulonephritis as a Paraneoplastic Syndrome Secondary to Urachal Adenocarcinoma: An Unknown Entity.

Acute Glomerulonephritis as a Paraneoplastic Syndrome Secondary to Urachal Adenocarcinoma: An Unknown Entity.

Journal: Cureus
Published: May 11, 2024

Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors.

Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors.

Journal: Clinical breast cancer
Published: November 30, 2023

Effect of receiving a customizable brochure on breast cancer patients' knowledge about their diagnosis and treatment: A randomized clinical trial.

Effect of receiving a customizable brochure on breast cancer patients' knowledge about their diagnosis and treatment: A randomized clinical trial.

Journal: Cancer medicine
Published: October 25, 2022

Quality of life with cemiplimab plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: Patient-reported outcomes from phase 3 EMPOWER-Lung 3.

Quality of life with cemiplimab plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: Patient-reported outcomes from phase 3 EMPOWER-Lung 3.

Journal: Cancer
Published: July 19, 2022

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial.

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial.

Journal: Nature medicine
Published: May 23, 2022

Factors associated with the desire to undergo post-mastectomy breast reconstruction in a Mexican breast cancer center.

Factors associated with the desire to undergo post-mastectomy breast reconstruction in a Mexican breast cancer center.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 02, 2020

High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.

High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.

Journal: European journal of haematology
Published: March 01, 2013
Showing 1-9 of 9

Last Updated: 09/26/2026